The Feasibility and Efficacy of Dose Timing (Morning vs Evening) of Temozolomide in the Treatment of Glioblastoma
Clinical trial NCT06850766 · RECRUITING
Trial details
- NCT number
- NCT06850766
- Sponsor
- Ottawa Hospital Research Institute
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-08
- Primary completion
- 2027-05-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.